Follow
Harish Dureja
Harish Dureja
Professor, Deptt of Pharm. Sci., M. D. University, Rohtak
Verified email at mdu.ac.in
Title
Cited by
Cited by
Year
Mouth dissolving tablets: A review
D Kaushik, H Dureja, TR Saini
INDIAN DRUGS-BOMBAY- 41 (4), 187-193, 2004
2392004
Cosmeceuticals: An emerging concept
H Dureja, D Kaushik, M Gupta, V Kumar, V Lather
Indian Journal of Pharmacology 37 (3), 155, 2005
1782005
Developments in nutraceuticals
H Dureja, D Kaushik, V Kumar
Indian journal of pharmacology 35 (6), 363-372, 2003
1282003
Simulation of Skin Permeability in Chitosan Membranes
Dureja Harish, Tiwary A. K. and Gupta Sunil
International Journal of Pharmaceutics 213, 193-198, 2001
1202001
Predicting anti-HIV-1 activity of 6-arylbenzonitriles: Computational approach using superaugmented eccentric connectivity topochemical indices
H Dureja, S Gupta, AK Madan
Journal of Molecular Graphics and Modelling 26 (6), 1020-1029, 2008
972008
Superaugmented eccentric connectivity indices: new-generation highly discriminating topological descriptors for QSAR/QSPR modeling
H Dureja, AK Madan
Medicinal Chemistry Research 16 (7), 331-341, 2007
892007
Anti‐inflammatory and anticancer activities of Naringenin‐loaded liquid crystalline nanoparticles in vitro
R Wadhwa, KR Paudel, LH Chin, CM Hon, T Madheswaran, G Gupta, ...
Journal of food biochemistry 45 (1), e13572, 2021
852021
Interactions with the macrophages: an emerging targeted approach using novel drug delivery systems in respiratory diseases
M Mehta, N Sharma, M Vyas, N Khurana, PK Maurya, H Singh, ...
Chemico-biological interactions 304, 10-19, 2019
722019
Formulation and evaluation of olanzapine mouth dissolving tablets by effervescent formulation approach
D Kaushik, H Dureja, TR Saini
INDIAN DRUGS-BOMBAY- 41, 410-412, 2004
712004
Topochemical models for prediction of cyclin-dependent kinase 2 inhibitory activity of indole-2-ones
H Dureja, AK Madan
Journal of Molecular Modeling 11 (6), 525-531, 2005
682005
Orally disintegrating tablets: An overview of melt-in mouth tablet technologies and techniques
D Kaushik, H Dureja, TR Saini
Tablets capsules 2 (1), 30-6, 2004
632004
Evidence of coronavirus (CoV) pathogenesis and emerging pathogen SARS-CoV-2 in the nervous system: a review on neurological impairments and manifestations
NK Jha, S Ojha, SK Jha, H Dureja, SK Singh, SD Shukla, DK Chellappan, ...
Journal of Molecular Neuroscience 71 (11), 2192-2209, 2021
592021
Albumin Nano-Encapsulation of Piceatannol Enhances Its Anticancer Potential in Colon Cancer via Down Regulation of Nuclear p65 and HIF-1α
A AA Aljabali, H A. Bakshi, F L. Hakkim, YA Haggag, K M. Al-Batanyeh, ...
Cancers 12 (1), 113, 2020
542020
Cellular signalling pathways mediating the pathogenesis of chronic inflammatory respiratory diseases: an update
M Mehta, DS Dhanjal, KR Paudel, B Singh, G Gupta, S Rajeshkumar, ...
Inflammopharmacology 28 (4), 795-817, 2020
522020
Formulation development and evaluation of alginate microspheres of ibuprofen
M Nagpal, DK Maheshwari, P Rakha, H Dureja, S Goyal, G Dhingra
Journal of Young Pharmacists 4 (1), 13-16, 2012
472012
Topological models for prediction of pharmacokinetic parameters of cephalosporins using random forest, decision tree and moving average analysis
H DUREJA, S GUPTA, AK MADAN
Scientia Pharmaceutica 76 (3), 377-394, 2008
472008
Nanoparticle technology for the delivery of poorly water-soluble drugs
V Kharb, M Bhatia, H Dureja, D Kaushik
Pharmaceutical technology (2003) 30 (2), 2006
462006
Targeting neutrophils using novel drug delivery systems in chronic respiratory diseases
DK Chellappan, LW Yee, KY Xuan, K Kunalan, LC Rou, LS Jean, LY Ying, ...
Drug development research 81 (4), 419-436, 2020
412020
Development and optimization of boswellic acid-loaded proniosomal gel
M Mehta, H Dureja, M Garg
Drug delivery 23 (8), 3072-3081, 2016
402016
What is computational toxicology?
B Reisfeld, AN Mayeno
Computational Toxicology, 3-7, 2012
392012
The system can't perform the operation now. Try again later.
Articles 1–20